- ►annals.org DH Blankenhorn, SP Azen, DM Kramsch, WJ … - Annals of internal medicine, 1993 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To assess the effects of lipid-lowering therapy with lovastatin ... Cited by 499 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org [PDF] D Waters, L Higginson, P Gladstone, B … - Circulation, 1994 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams &
Wilkins, a division of Wolters ... Effects of Monotherapy With an HMG-CoA Cited by 319 - Related articles - BL Direct - All 5 versions
B Pitt, GBJ Mancini, SG Ellis, HS Rosman, … - Journal of the American College of Cardiology, 1995 - Elsevier Baseline mean LDL cholesterol was 164 mg/dl (4.24 mmol/liter). Pravastatin
decreased total and LDL cholesterol and triglyceride levels by 19%, 28% and 8%,
respectively, and increased high density lipoprotein cholesterol by 7% (p ... Cited by 317 - Related articles - BL Direct - All 6 versions
JW Jukema, AVG Bruschke, AJ van Boven, … - Circulation, 1995 - Am Heart Assoc Methods and Results REGRESS is a double-blind, placebo-controlled multicenter
study to assess the effects of 2 years of treatment with the
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor pravastatin on ... Cited by 577 - Related articles - BL Direct - All 5 versions
IE Now - The Lancet, 1992 - thelancet.com To assess the effect of dietary reduction of plasma cholesterol concentrations
on coronary atherosclerosis, we set up a randomised, controlled,
end-point-blinded trial based on quantitative image analysis of coronary ... Cited by 658 - Related articles - Cached - All 7 versions
JP Kane, MJ Malloy, TA Ports, NR Phillips, JC … - Jama, 1990 - Am Med Assoc We conducted a randomized, controlled trial in 72 patients with heterozygous
familial hypercholesterolemia to test whether reducing plasma low-density
lipoprotein levels by diet and combined drug regimens can induce regression ... Cited by 654 - Related articles - All 4 versions
G Brown, JJ Albers, LD Fisher, SM Schaefer, … - New England Journal of Medicine, 1990 - content.nejm.org BACKGROUND AND METHODS. The effect of intensive lipid-lowering therapy on
coronary atherosclerosis among men at high risk for cardiovascular events was
assessed by quantitative arteriography. Of 146 men no more than 62 years of ... Cited by 1695 - Related articles - All 7 versions
WJ Mack, SP Azen, M Dunn, HN Hodis - Controlled clinical trials, 1997 - Elsevier The Monitored Atherosclerosis Regression Study was a double-blind, 2-year,
placebo-controlled, randomized, serial angiographic trial which tested reduction
of low density lipoprotein-cholesterol with monotherapy using lovastatin on ... Cited by 6 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org [PDF] HP Bestehorn, UFE Rensing, H Roskamm, P … - European heart journal, 1997 - Eur Soc Cardiology Methods and results In the Coronary Intervention Study (CIS), a multicentre
randomized double-blind placebo- controlled study, the effects of lipid-lowering
therapy with simvastatin on progression of coronary artery disease in 254 ... Cited by 80 - Related articles - BL Direct - All 4 versions
[CITATION] for the PLAC I Investigators. Pravastatin Limitation of Atherosclerosis in the Coronary …
